Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-016104

Director acquired 952 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Young Caroline Director 2023-11-01 Other acquisition 10b5-1 +55 $1.85 $102 23,630 D
Young Caroline Director 2023-11-02 Other acquisition 10b5-1 +55 $1.97 $108 23,685 D
Young Caroline Director 2023-11-03 Other acquisition 10b5-1 +55 $2.06 $113 23,740 D
Young Caroline Director 2023-11-06 Other acquisition 10b5-1 +55 $2.03 $112 23,795 D
Young Caroline Director 2023-11-07 Other acquisition 10b5-1 +19 $2.01 $38 23,814 D
Young Caroline Director 2023-11-08 Other acquisition 10b5-1 +55 $2.00 $110 23,869 D
Young Caroline Director 2023-11-09 Other acquisition 10b5-1 +55 $1.82 $100 23,924 D
Young Caroline Director 2023-11-10 Other acquisition 10b5-1 +55 $1.77 $97 23,979 D
Young Caroline Director 2023-11-13 Other acquisition 10b5-1 +46 $1.75 $81 24,025 D
Young Caroline Director 2023-11-14 Other acquisition 10b5-1 +55 $1.73 $95 24,080 D
Young Caroline Director 2023-11-15 Other acquisition 10b5-1 +55 $1.78 $98 24,135 D
Young Caroline Director 2023-11-16 Other acquisition 10b5-1 +13 $1.73 $22 24,148 D
Young Caroline Director 2023-11-17 Other acquisition 10b5-1 +55 $1.83 $101 24,203 D
Young Caroline Director 2023-11-20 Other acquisition 10b5-1 +53 $1.70 $90 24,256 D
Young Caroline Director 2023-11-21 Other acquisition 10b5-1 +25 $1.76 $44 24,281 D
Young Caroline Director 2023-11-22 Other acquisition 10b5-1 +55 $1.74 $96 24,336 D
Young Caroline Director 2023-11-27 Other acquisition 10b5-1 +72 $1.86 $134 24,408 D
Young Caroline Director 2023-11-28 Other acquisition 10b5-1 +25 $1.68 $42 24,433 D
Young Caroline Director 2023-11-29 Other acquisition 10b5-1 +32 $1.73 $55 24,465 D
Young Caroline Director 2023-11-30 Other acquisition 10b5-1 +62 $1.66 $103 24,527 D
Loading xslF345X05/marketforms-63726.xml…